A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract.

Source:http://linkedlifedata.com/resource/pubmed/id/19782419

Download in:

View as

General Info

PMID
19782419